Nasopharyngeal angiofibroma is a histologically benign but locally aggressive vascular tumor that grows in the back of the nasal cavity. It most commonly affects adolescent males and may grow into fissures of the. Nasoangiofibroma youth is a highly vascularized tumor almost exclusively male adolescents presentation. % represents % of head and. Angiofibroma nasofaring juvenile – Free download as PDF File .pdf), Text File . txt) or read online for free.
|Published (Last):||19 June 2007|
|PDF File Size:||13.22 Mb|
|ePub File Size:||16.12 Mb|
|Price:||Free* [*Free Regsitration Required]|
Preoperative embolisation of tumour may be of some use in reducing intraoperative bleeding. Loss of expression of GSTM 1 null genotype is seen in this tumor. The tumor is primarily excised by external or endoscopic approach. Removal is important in preventing nasal obstruction and recurrent epistaxis. Mast cells and T-lymphocytes in juvenile angiofibromas.
Early diagnosis and treatment are required nzsofaring a good prognosis in JNA. Bilateral vascular supply in juvenile nasopharyngeal angiofibromas.
Juvenile nasopharyngeal angiofibroma
Edit article Share article View revision history. Supply of these tumours is usually via Eventually, the tumor may invade the infratemporal fossa and the middle cranial fossa.
It impinges on adjacent structures and causes pressure erosion of bone. Irradiation may be an option if surgery is not possible or only incomplete resection achieved 2,4,6.
Intraoral nasofaribg was diffuse, obliterating the vestibule and extending from the lateral incisor anteriorly till the pharynx posteriorly [ Figure 1 ].
Imaging in the diagnosis of juvenile nasopharyngeal angiofibroma. Histopathological examination revealed a proliferative connective tissue stroma interspersed with a thick vascular network. Nasal cavity, paranasal sinuses, nasopharynx Other tumors Nasopharyngeal angiofibroma Author: This page was last edited on 29 Septemberat The muscular lining of the blood vessel is absent in small and incomplete in larger vessels. Plain radiographs no longer play a role in the workup of a suspected juvenile nasopharyngeal angiofibroma, however they may still be obtained in some instances during the assessment of nasal obstruction, or symptoms of sinus obstructions.
Pathology Outlines – Nasopharyngeal angiofibroma
Juvenile nasopharyngeal angiofibroma JNA is a benign neoplasm of the nasopharynx. Articles from Nasofafing of Oral and Maxillofacial Pathology: J Clin Imaging Sci. Ear Nose Throat J. These discrepancies may be due to the monoclonal antibodies which detect only alpha-ER and not the beta ER protein. Clinical examination reveals a firm and friable mass in the nasopharynx and nose. Numerous mast cells were noted with a minimal inflammatory cell infiltrate.
Juvenile nasopharyngeal angiofibroma | Radiology Reference Article |
Type III is a calabash-like massive tumor lobe in the middle cranial fossa. He had no noteworthy family history or past medical history. CT is particularly useful at delineating bony changes. Open in a separate window.
Prognosis for nasopharyngeal angiofibroma is favorable. Extensive bony destruction is usually not a feature, but rather bone is remodelled or resorbed.
A wait and watch policy with periodic imaging may thus postpone or eliminate the need for surgery and reduce morbidity.
The main clinical presentation of JNA is unilateral nasal obstruction with or without epistaxis. Unable to process the form. As this tumor is aggressive and expansile, it invades adjacent structures causing further symptoms. Case 1 Case 1.
JNA is benign but locally destructive. You can also scroll through stacks with your mouse wheel or the keyboard arrow keys. Case 3 Case 3. Sagittal angifibroma in computed tomography scans showing site and extent of the lesion.
Intraoral view showing swelling on the upper left side of the maxilla and obliteration of the vestibule.
Retrieved from ” https: Support Radiopaedia and see fewer ads. These techniques help to establish the exact site, extension and relation of the tumor to the adjacent structures such as blood vessels and nerves. MRI is used posttreatment to detect residual or recurrent tumor mass and to monitor the effects of radiotherapy.
Treatment trends in patients during 40 years.